2565-01-7 Usage
Description
(6aS)-1,2-dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-benzo[de][1,3]benzodioxolo[5,6-g]quinoline is a complex organic compound characterized by its unique chemical structure. It features methoxy and methyl groups, as well as a tetrahydrobenzodioxoloquinoline ring system. The combination of these functional groups and ring structures endows the compound with potential pharmacological and biological activities.
Uses
Due to the provided materials, there are no specific applications mentioned for (6aS)-1,2-dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-benzo[de][1,3]benzodioxolo[5,6-g]quinoline. However, given its complex structure and potential pharmacological and biological activities, it may be used in various industries upon further research and development. Possible applications could include:
Used in Pharmaceutical Industry:
(6aS)-1,2-dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-benzo[de][1,3]benzodioxolo[5,6-g]quinoline could be used as a pharmaceutical agent for [specific medical condition or treatment] due to its potential pharmacological properties.
Used in Chemical Research:
In the field of chemical research, (6aS)-1,2-dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-benzo[de][1,3]benzodioxolo[5,6-g]quinoline may serve as a subject for studying the effects of its functional groups and ring systems on its chemical behavior and potential interactions with other compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 2565-01-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,5,6 and 5 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 2565-01:
(6*2)+(5*5)+(4*6)+(3*5)+(2*0)+(1*1)=77
77 % 10 = 7
So 2565-01-7 is a valid CAS Registry Number.
2565-01-7Relevant articles and documents
Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine
LeGendre, Onica,Pecic, Stevan,Chaudhary, Sandeep,Zimmerman, Sarah M.,Fantegrossi, William E.,Harding, Wayne W.
, p. 628 - 631 (2010)
The naturally occurring aporphine alkaloid nantenine, has been shown to antagonize behavioral and physiological effects of MDMA in mice. We have synthesized (±)-nantenine via an oxidative cyclization reaction with PIFA and evaluated its binding profile against a panel of CNS targets. To begin to understand the importance of the chiral center of nantenine with regards to its capacity to antagonize the effects of MDMA in vivo, (R)- and (S)-nantenine were prepared and evaluated in a food-reinforced operant task in rats. Pretreatment with either nantenine enantiomer (0.3 mg/kg ip) completely blocked the behavioral suppression induced upon administration of 3.0 mg/kg MDMA. (±)-Nantenine displayed high affinity and selectivity for the α1A adrenergic receptor among several other receptors suggesting that this α1 subtype may be significantly involved in the anti-MDMA effects of the enantiomers.